LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 7.77 | 84.90 | 790 | 411 | 1.9210 | 1.6644 | MN20160318_Q02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 9.47 | 84.90 | 2 | 447 | 0.0045 | -0.7905 | MN20160318_Q02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 9.47 | 84.90 | 920 | 447 | 2.0562 | 1.7014 | MN20160318_Q02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 9.47 | 84.90 | 6 | 447 | 0.0134 | -0.6688 | MN20160318_Q02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 9.47 | 84.90 | 877 | 447 | 1.9601 | 1.6480 | MN20160318_Q02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 11.18 | 84.90 | 11 | 492 | 0.0223 | -0.5533 | MN20160318_Q02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 11.18 | 84.90 | 972 | 492 | 1.9742 | 1.6152 | MN20160318_Q02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 11.18 | 84.90 | 24 | 492 | 0.0487 | -0.3924 | MN20160318_Q02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 11.18 | 84.90 | 934 | 492 | 1.8970 | 1.5744 | MN20160318_Q02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 12.88 | 84.90 | 15 | 531 | 0.0282 | -0.4808 | MN20160318_Q02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 12.88 | 84.90 | 1002 | 531 | 1.8870 | 1.5427 | MN20160318_Q02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 12.88 | 84.90 | 24 | 531 | 0.0452 | -0.3798 | MN20160318_Q02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 12.88 | 84.90 | 967 | 531 | 1.8211 | 1.5087 | MN20160318_Q02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 14.58 | 84.90 | 21 | 663 | 0.0317 | -0.3756 | MN20160318_Q02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 14.58 | 84.90 | 1052 | 663 | 1.5858 | 1.3364 | MN20160318_Q02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 14.58 | 84.90 | 17 | 663 | 0.0256 | -0.4185 | MN20160318_Q02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 14.58 | 84.90 | 1001 | 663 | 1.5089 | 1.2975 | MN20160318_Q02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 16.29 | 84.90 | 27 | 766 | 0.0352 | -0.3029 | MN20160318_Q02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 16.29 | 84.90 | 1113 | 766 | 1.4514 | 1.2490 | MN20160318_Q02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 16.29 | 84.90 | 22 | 766 | 0.0287 | -0.3464 | MN20160318_Q02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 16.29 | 84.90 | 1084 | 766 | 1.4136 | 1.2303 | MN20160318_Q02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 17.99 | 84.90 | 30 | 898 | 0.0334 | -0.2633 | MN20160318_Q02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 17.99 | 84.90 | 1174 | 898 | 1.3059 | 1.1631 | MN20160318_Q02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 17.99 | 84.90 | 24 | 898 | 0.0267 | -0.3100 | MN20160318_Q02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 17.99 | 84.90 | 1176 | 898 | 1.3082 | 1.1642 | MN20160318_Q02 | E21 |